Resources/Blogs
Blogs

MTM in Healthcare: What Medication Therapy Management Means for Patients

Team Circle Health
Team Circle Health
Author
June 11, 20265 min read
MTM in Healthcare: What Medication Therapy Management Means for Patients

What Medication Therapy Management (MTM) is, who qualifies, how it works, and how it improves medication safety and chronic disease care.

If you take multiple prescription medications for ongoing health conditions, there is a good chance you qualify for a program most patients have never heard of - and even fewer have used. Medication Therapy Management, or MTM, is a structured service available at no cost to eligible Medicare beneficiaries that ensures every medication you take is safe, necessary, and working as intended. This guide explains what MTM is, who it is designed for, what actually happens during a session, and why it matters for your health.

What Is Medication Therapy Management?

Medication Therapy Management is a patient-centered service in which a licensed pharmacist or other qualified healthcare provider reviews your complete medication profile - every prescription drug, over-the-counter medication, vitamin, and herbal supplement - to identify problems, improve your understanding, and optimize your treatment outcomes.

MTM was introduced through the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 as a required component of Medicare Part D. Per CMS's MTM program requirements, all Medicare Part D plans must offer MTM services to eligible beneficiaries, and the service is provided at no additional cost to the patient.

What MTM is not:

  • It is not a prescription drug benefit
  • It is not the same as a regular pharmacy consultation at the counter
  • It is not a one-time medication pickup interaction
  • It is not a physician visit focused on diagnosing or treating illness

MTM is specifically a structured, dedicated clinical service focused on reviewing, optimizing, and coordinating the medications you are already taking.

Who Qualifies for MTM?

Eligibility for MTM under Medicare Part D is determined by each plan but must follow CMS minimum criteria. To qualify, patients must have multiple chronic conditions, take multiple Part D covered medications, and are likely to spend more than $1,276 in 2026 in annual out-of-pocket costs for covered Part D drugs. Circle Health

The ten core chronic conditions CMS requires plans to target:

  • Alzheimer's disease and related dementia
  • Chronic heart failure (CHF)
  • Diabetes
  • Dyslipidemia (high cholesterol)
  • End-stage renal disease (ESRD)
  • Hypertension
  • Mental health disorders (depression, schizophrenia, bipolar disorder)
  • Respiratory disease (asthma, COPD)
  • Rheumatoid arthritis or osteoarthritis
  • Bone disease (osteoporosis, osteopenia)

In January 2026, CMS expanded MTM eligibility in Medicare Part D - changing the criteria to reflect patients taking five or more chronic medications, down from eight - making the program accessible to a significantly broader population of Medicare beneficiaries in Circle Care

What Happens During an MTM Session?

There are two types of MTM services patients may receive: a Comprehensive Medication Review (CMR) and a Targeted Medication Review (TMR).

Comprehensive Medication Review (CMR)

The CMR is the core MTM service - a one-on-one, interactive review of every medication you take with a qualified pharmacist or healthcare provider.

What the CMR covers:

  • A complete inventory of all prescriptions, over-the-counter drugs, vitamins, and supplements
  • A review of whether each medication is still necessary and appropriate for your current conditions
  • Identification of potential drug interactions - including between medications prescribed by different providers
  • A check for duplicate therapies - cases where two medications serve the same purpose
  • A review of dosing accuracy and whether you are taking each medication correctly
  • Identification of any side effects you may be experiencing that have not been discussed with your doctor
  • A discussion of lower-cost alternatives where clinically appropriate

The CMR can be done over the phone or via telehealth and typically takes about 20–30 minutes to complete. The pharmacist will look at all the medicines you are taking, even the ones you buy without a prescription.

After the CMR, you receive two important documents:

  • Personal Medication Record (PMR) - A complete list of every medication you take, including dose, frequency, purpose, and prescribing provider
  • Medication-Related Action Plan (MAP) - A prioritized list of recommended next steps for you and your healthcare team, written in plain language

Targeted Medication Review (TMR)

The TMR is a shorter, focused review conducted between CMRs - typically every quarter. Rather than reviewing your entire medication profile, the TMR addresses a specific concern: a new medication, a recent change in condition, or a potential interaction flagged by the pharmacist.

Why MTM Matters: The Patient Safety Problem It Solves

The scale of medication-related problems in the U.S. healthcare system is substantial. Health practices across the U.S. currently experience around 3 million emergency visits per year as a result of adverse drug events. MTM can reduce such roadblocks and enable providers to offer better care to patients.

For patients managing multiple chronic conditions with multiple prescribers, medication problems are not hypothetical risks - they are common realities:

  • Polypharmacy complications - Taking five or more medications significantly increases the risk of drug interactions, side effects, and dosing errors
  • Prescriber fragmentation - A cardiologist, endocrinologist, and primary care physician each prescribing independently may not have a complete picture of the patient's full medication burden
  • Adherence gaps - Side effects, complex dosing schedules, and cost concerns cause patients to stop or modify medications without telling their provider
  • Duplicate therapy - The same condition treated by two different medications from two different providers - generating cost and risk without clinical benefit

MTM addresses all four problems within a single structured session.

For patients whose conditions are also managed through Chronic Care Management programs, MTM serves as a complementary layer - where CCM handles ongoing care coordination and proactive monitoring, MTM specifically optimizes the medication component of that care plan.

How MTM Fits Into a Broader Care Management Plan

MTM does not operate in isolation. It is most effective when the findings from a CMR are communicated directly to the patient's prescribing physicians and integrated into the broader care plan.

The ideal MTM workflow:

  1. Patient is identified as eligible and enrolled automatically or by provider referral
  2. CMR is completed by phone, telehealth, or in person
  3. PMR and MAP are sent to both the patient and the prescribing physician
  4. The physician reviews the pharmacist's recommendations and acts on those within their clinical scope
  5. TMRs track follow-through on MAP recommendations quarterly

Per CMS guidance on chronic care management and care coordination, medication management is especially important for patients managing behavioral health conditions alongside chronic physical conditions - where psychiatric medications may interact with cardiovascular or metabolic drugs in ways that require coordinated oversight across multiple providers. For patients managing both chronic disease and behavioral health conditions, understanding how behavioral health integration connects to medication and care management provides important context for how MTM fits within a coordinated care model.

2026 Changes That Expand MTM Access

2026 Changes That Expand MTM Access

Two significant changes in 2026 make MTM available to more patients than at any previous point:

1. Lower medication threshold: CMS expanded MTM eligibility in January 2026 - patients taking five or more chronic medications now qualify, down from the previous threshold of eight. This change adds millions of additional Medicare beneficiaries to the eligible population. Circle Care

2. Telehealth delivery permanently available: CMRs and TMRs can now be conducted via two-way audio-visual telehealth or audio-only for patients without video access - removing the geographic and mobility barriers that previously prevented rural and homebound patients from accessing MTM services.

3. AI-assisted medication review: Healthcare organizations are now implementing platforms powered by AI to analyze medication profiles, flag potential drug interactions, and suggest optimization strategies - built into EHR systems to allow pharmacists and care teams to conduct more thorough reviews in less time.

Conclusion

Medication Therapy Management is one of the most underutilized free services available to Medicare patients. For anyone taking multiple medications for ongoing conditions, a CMR with a qualified pharmacist can identify drug interactions, eliminate unnecessary medications, improve adherence, and reduce the risk of an adverse drug event - all at no cost. The 2026 eligibility expansion means more patients qualify than ever before. If you have not been enrolled or been told you qualify, asking your Medicare Part D plan directly is the simplest first step.

For providers integrating MTM into chronic disease care programs, the full scope of how MTM billing works alongside CCM and RPM - and the combined clinical and financial value that integration creates - is the practical next layer beyond understanding what MTM means for patients.

Frequently Asked Questions

Q1. Is MTM the same as medication reconciliation?

Not exactly. Medication reconciliation ensures medication lists are accurate during care transitions, while MTM is a comprehensive review focused on medication safety, effectiveness, and optimization.

Q2. Does MTM cost anything for Medicare patients?

No. MTM services are provided at no additional cost to eligible Medicare Part D beneficiaries through participating health plans.

Q3. Can I request an MTM session, or do I have to wait to be contacted?

Both. Eligible patients are often contacted by their health plan, but you can also request an MTM session directly through your Medicare Part D provider.

Q4. What happens if the pharmacist identifies a problem with my medications?

The pharmacist documents recommendations, shares them with your healthcare provider, and provides you with an action plan for follow-up and medication management.

Q5. How often can I have an MTM session?

Patients typically receive at least one Comprehensive Medication Review annually, along with periodic Targeted Medication Reviews throughout the year.

Tags:

BlogsGeneralHealthcare

Share this article:

Ready to get started?Request Demo